The preventive and therapeutic role of physical activity in knee osteoarthritis
Submitted: 20 October 2021
Accepted: 18 February 2022
Published: 3 May 2022
Accepted: 18 February 2022
Abstract Views: 9100
PDF: 3713
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. D'Angelo, C. Palazzi, I. Olivieri, Psoriatic arthritis: treatment strategies using biologic agents , Reumatismo: Vol. 64 No. 2 (2012)
- S.M. Gamal, A.K. Alkemary, M.A. Abdo, A.H.M. El Dakrony, Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices , Reumatismo: Vol. 70 No. 2 (2018)
- M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso, Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy , Reumatismo: Vol. 74 No. 3 (2022)
- A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli, Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity , Reumatismo: Vol. 64 No. 5 (2012)
- G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio, Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life , Reumatismo: Vol. 72 No. 2 (2020)
- I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula, Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis , Reumatismo: Vol. 65 No. 1 (2013)
- M. Lorenzin, A. Ortolan, P. Frallonardo, S. Vio, C. Lacognata, F. Oliviero, L. Punzi, R. Ramonda, Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study , Reumatismo: Vol. 68 No. 2 (2016)
- F. Atzeni, S. Sallì, M. Benucci, M. Di Franco, R. Casale, A. Alciati, P. Sarzi-Puttini, Fibromyalgia and arthritides , Reumatismo: Vol. 64 No. 4 (2012)
- F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo, Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review , Reumatismo: Vol. 75 No. 1 (2023)
- A. Spadaro, A. Scarno, A. Carboni, F.M. Perrotta, C. Catalano, E. Lubrano, G. Valesini, Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis , Reumatismo: Vol. 65 No. 3 (2013)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
You may also start an advanced similarity search for this article.